Skip to main content
VCbacked
Log inGet Started

Aardvark Therapeutics

San Diego, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

$85.0M raised
May 2024
Series C
BiotechnologyHealth CareTherapeutics

Top Investors

Cormorant Asset ManagementWalleye CapitalDecheng CapitalPremier PartnersVickers Venture Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aardvark Therapeutics

How much funding has Aardvark Therapeutics raised?
Aardvark Therapeutics has raised $85.0M in total funding. The most recent round was Series C. The last funding was announced in May 2024.
Who are Aardvark Therapeutics's investors?
Aardvark Therapeutics's investors include Cormorant Asset Management, Walleye Capital, Decheng Capital, Premier Partners, Vickers Venture Partners.
Where is Aardvark Therapeutics headquartered?
Aardvark Therapeutics is headquartered in San Diego, United States.
What does Aardvark Therapeutics do?
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
What stage is Aardvark Therapeutics at?
Aardvark Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aardvark Therapeutics — Funding & Investors." VCBacked, May 9, 2024, https://www.vcbacked.co/company/aardvark-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Aardvark Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/aardvark-therapeutics
Wikipedia (cite web)
{{cite web |title=Aardvark Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aardvark-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong